GlassScriptPhysician profile
Darin T Johnston
NPI 1659757250
$1,280.35
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $384 · 2020: $18.74 · 2021: $145 · 2023: $208 · 2024: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $583 · Travel and Lodging: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $582.53 |
| Travel and Lodging | $150.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $443.05 | 2024 | Na |
| Medical Device Business Services, INC. | $348.00 | 2019 | |
| Kls-Martin L.P. | $90.77 | 2023 | |
| Zimmer Biomet Holdings, INC. | $68.98 | 2023-2024 | Neuro Plating System, Tmj System |
| Nobel Biocare USA | $53.86 | 2023 | Nobelactive |
| Tela Bio, INC. | $51.31 | 2021 | |
| Acera Surgical, INC. | $50.00 | 2021 | |
| Integra Lifesciences Corporation | $43.75 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $36.53 | 2019-2020 | |
| Daiichi Sankyo INC. | $29.47 | 2024 | Enhertu |
| Axogen | $18.16 | 2019 | |
| Geistlich Pharma, North America, INC. | $17.37 | 2024 | Geistlich Bio-Gide |
| Incyte Corporation | $15.82 | 2023 | Pemazyre, Monjuvi |
| Straumann USA LLC | $13.28 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darin Johnston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.